Table 3.
Element/Functionality | |
---|---|
Treatment plan core elements | Flow sheet: inclusive of all chemotherapy, |
Demographics, including referring provider and PCP | non-chemotherapy medications, transfusions, tumor measurements, lab values |
Diagnosis: ICD-9 or 10; possibly more clinically relevant system | |
Flow sheet: physical findings, including tumor measurements, imaging, relevant procedures, nursing assessment* | |
Stage | |
AJCC for relevant diagnoses: tumor registry staging system for other diagnoses | |
Oncology-specific review of systems | |
Disease status at each course of therapy | Patient provided with copy of treatment plan and summary |
Site/histology/pathology findings: menu-driven by disease | |
Intent/goals of therapy: adjuvant/curative v palliative | Documentation of investigational drugs |
Performance status | Capture date of death* |
List of comorbid conditions expected to complicate chemotherapy, eg, hepatic insufficiency | Oncology-specific EHR functions |
EHR-generated treatment plan | |
Cancer surgical history | EHR-generated treatment summary |
Chemotherapy/biotherapy regimen planned | Ability to update treatment summary |
Body surface area and starting doses | EHR application to generate specific reports, eg, specific types of flow sheets |
Duration of treatment and number of planned cycles | |
Major toxicities associated with planned treatment | Mechanism to capture verbal orders* |
Radiation therapy planned or previously delivered | Drug interaction alerts |
Pain assessment and supportive care needs: advanced cancer | Basic safety limits for dosing |
Body surface area safety monitoring | |
Treatment on clinical trial | Lifetime cumulative chemotherapy dose |
Sites of disease monitored: advanced cancer eligibility* | Clinical decision support, eg, guidelines or trial |
Treatment summary core elements | |
Patient demographics | Treatment preauthorization support* |
Chemotherapy/biotherapy delivered: IV and oral | Drug inventory control* |
Number of cycles planned and administered | Internal and external communications* |
Duration: date of first and last dose | Import key external reports, eg, pathology, operative note, radiation |
Extent of dose reduction | |
Reason treatment stopped | Radiofrequency identification technology for patient/drugs given, eg, barcodes* |
Major toxicities experienced | |
Hospitalization required for toxicity | Open database with query capabilities* |
Disease status at completion of treatment | Interoperability: health information exchange with labs, imaging centers, etc.* |
Performance status at completion of treatment | |
Coordination of follow-up care | Compliance safeguards |
Provider contacts | Privacy and security safeguards in place |
Other oncology-specific documentation | Disaster recovery plan in place |
Abbreviations: EHR, electronic health record; PCP, primary care physician; ICD-9, International Classification of Diseases, 9th Edition; AJCC, American Joint Committee on Cancer.
* Denotes elements characterized by Roundtable participants as desirable, not critical.